<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genet Mol Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Genet. Mol. Biol</journal-id>
<journal-id journal-id-type="publisher-id">gmb</journal-id>
<journal-title-group>
<journal-title>Genetics and Molecular Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1415-4757</issn>
<issn pub-type="epub">1678-4685</issn>
<publisher>
<publisher-name>Sociedade Brasileira de Genética</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28534929</article-id>
<article-id pub-id-type="pmc">5488458</article-id>
<article-id pub-id-type="doi">10.1590/1678-4685-GMB-2016-0179</article-id>
<article-id pub-id-type="publisher-id" specific-use="previous-pid">S1415-47572017005014103</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Teratogens: a public health issue – a Brazilian overview</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mazzu-Nascimento</surname>
<given-names>Thiago</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Melo</surname>
<given-names>Débora Gusmão</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morbioli</surname>
<given-names>Giorgio Gianini</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carrilho</surname>
<given-names>Emanuel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vianna</surname>
<given-names>Fernanda Sales Luiz</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>da Silva</surname>
<given-names>André Anjos</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schuler-Faccini</surname>
<given-names>Lavinia</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<aff id="aff1"><label>1</label>Instituto de Química de São Carlos, Universidade de São Paulo, São
Carlos, SP, Brazil</aff>
<aff id="aff2"><label>2</label>Instituto Nacional de Ciência e Tecnologia de Bioanalítica, Campinas,
SP, Brazil</aff>
<aff id="aff3"><label>3</label>Departamento de Medicina, Centro de Ciências Biológicas e da Saúde,
Universidade Federal de São Carlos, São Carlos, SP, Brazil</aff>
<aff id="aff4"><label>4</label>School of Chemistry and Biochemistry, Georgia Institute of
Technology, Atlanta, GA, USA</aff>
<aff id="aff5"><label>5</label>Sistema Nacional de Informação sobre Agentes Teratogênicos (SIAT),
Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil</aff>
<aff id="aff6"><label>6</label>Programa de Pós-Graduação em Genética e Biologia Molecular,
Departamento de Genética, Instituto de Biociências, Universidade Federal do Rio
Grande do Sul, Porto Alegre, RS, Brazil</aff>
<aff id="aff7"><label>7</label>UNIVATES University, Lajeado, RS, Brazil</aff>
</contrib-group>
<author-notes>
<corresp id="c1">Send correspondence to Lavinia Schuler-Faccini. Departamento de
Genética, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Caixa
postal 15053, Campus Agronomia, 91501-970 Porto Alegre, RS, Brazil. E-mail:
<email>lavinia.faccini@ufrgs.br</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<season>Apr-Jun</season>
<year>2017</year>
</pub-date>
<volume>40</volume>
<issue>2</issue>
<fpage>387</fpage>
<lpage>397</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017, Sociedade Brasileira de
Genética.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>License information: This is an open-access article distributed under the
terms of the Creative Commons Attribution License (type CC-BY), which permits
unrestricted use, distribution and reproduction in any medium, provided the
original article is properly cited.</license-p>
</license>
</permissions>
<abstract>
<title>Abstract</title>
<p>Congenital anomalies are already the second cause of infant mortality in Brazil, as
in many other middle-income countries in Latin America. Birth defects are a result of
both genetic and environmental factors, but a multifactorial etiology has been more
frequently observed. Here, we address the environmental causes of birth defects – or
teratogens – as a public health issue and present their mechanisms of action,
categories and their respective maternal-fetal deleterious effects. We also present a
survey from 2008 to 2013 of Brazilian cases involving congenital anomalies (annual
average of 20,205), fetal deaths (annual average of 1,530), infant hospitalizations
(annual average of 82,452), number of deaths of hospitalized infants (annual average
of 2,175), and the average cost of hospitalizations (annual cost of $7,758).
Moreover, we report on Brazilian cases of teratogenesis due to the recent Zika virus
infection, and to the use of misoprostol, thalidomide, alcohol and illicit drugs.
Special attention has been given to the Zika virus infection, now proven to be
responsible for the microcephaly outbreak in Brazil, with 8,039 cases under
investigation (from October 2015 to June 2016). From those cases, 1,616 were
confirmed and 324 deaths occurred due to microcephaly complications or alterations on
the central nervous system. Congenital anomalies impact life quality and raise costs
in specialized care, justifying the classification of teratogens as a public health
issue.</p>
</abstract>
<kwd-group>
<title>Keywords:</title>
<kwd>Birth defects</kwd>
<kwd>teratogens</kwd>
<kwd>Zika virus</kwd>
<kwd>pregnancy</kwd>
<kwd>public health</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="87"></ref-count>
<page-count count="11"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Background</title>
<p>Congenital anomalies are among the major causes of infant death worldwide (Brazilian
Ministry of Health, MoH) (<xref ref-type="bibr" rid="B29">Egbe <italic>et al.</italic>,
2015</xref>). In the United States, as in other high-income countries, birth defects
are the main cause of infant mortality, being responsible for 1 out of 5 infant deaths
(<xref ref-type="bibr" rid="B57">Petrini <italic>et al.</italic>, 2002</xref>).
Within the main causes of infant deaths in the United States, congenital malformations,
deformations and chromosomal abnormalities appear in first place, representing 20.3% of
total infant deaths in 2013 (<xref ref-type="bibr" rid="B81">Xu <italic>et al.</italic>,
2016</xref>). These are also the reasons for 12% of all pediatric hospitalizations
(<xref ref-type="bibr" rid="B29">Egbe <italic>et al.</italic>, 2015</xref>). In Latin
America, congenital anomalies are between the second and fifth cause of death in
children under 1 year of age (<xref ref-type="bibr" rid="B10">Bronberg <italic>et
al.</italic>, 2014</xref>). In Brazil, since 2000, they are the second main cause
of infant death (<xref ref-type="bibr" rid="B56">Passos-Bueno <italic>et al.</italic>,
2014</xref>), and among the three leading causes of infant hospitalizations,
responsible for 37% of pediatric hospital admissions. In addition, the hospital
mortality rate in children with malformations accounted for 9.8% of total deaths, almost
twice as in children without malformations (<xref ref-type="bibr" rid="B42">Horovitz
<italic>et al.</italic>, 2005</xref>).</p>
<p>Congenital anomalies affect about 1 in 33 liveborns, with an estimated 3.2 million
newborns with birth defects per year. Moreover, in 2013 a worldwide estimate showed that
nearly 276,000 newborns die before one month of life every year, as a result of these
congenital anomalies (<xref ref-type="bibr" rid="B85">World Health Organization,
2015a</xref>). From those, 10 to 25% present specific genetic inheritance, 10% are
caused by environmental factors, such as teratogens exposure, and 65 to 75% remain with
unknown causes, what may include polygenic diseases, multifactorial factors
(gene-environment interactions), spontaneous development abnormalities and synergistic
interactions with teratogens (<xref ref-type="bibr" rid="B9">Brent, 2001</xref>).</p>
<p>Teratogens are environmental agents such as drugs, viruses, lack of nutrients, and
physical or chemical elements that upon contact with embryo/fetus can cause congenital
anomalies, generating permanent functional or morphological changes in the newborn
(<xref ref-type="bibr" rid="B66">Shepard, 1982</xref>).</p>
<p>Among the main reasons for pregnant women having contact with teratogenic substances is
the association of preexisting public health problems (such as lack of medical care,
drug and alcohol consumption, lack of basic sanitation) to other social issues like
poverty and illiteracy (<xref ref-type="bibr" rid="B61">Reidpath and Allotey,
2003</xref>; <xref ref-type="bibr" rid="B85">World Health Organization,
2015a</xref>). Therefore, the offspring of socially disadvantaged women are more
vulnerable to birth defects, causing an impact on infant mortality and health expenses
with specialized care, qualifying teratogens as a public health problem.</p>
</sec>
<sec>
<title>Teratogenic agents</title>
<p>Ancient Egypt wall paintings suggest the long time existence of congenital
abnormalities, such as clubfoot and achondroplasia (<xref ref-type="bibr" rid="B7">Barrow, 1971</xref>). Children with congenital malformations were labeled as
“monsters” by the ancients (<xref ref-type="bibr" rid="B34">Garcias and Schüler-Faccini,
2004</xref>). Other regions, such as the Americas, Australia and Pacific Islands also
have early records of primitive sculptures revealing concerns with congenital anomalies,
which have even inspired some mythological figures (<xref ref-type="bibr" rid="B7">Barrow, 1971</xref>). Only in the 1930s malformations started to be scientifically
studied in animal models. Pioneer studies were performed in pig offspring, addressing
dietary vitamin A deficiency in pregnant sows, which caused a complete absence of eye
globe and ocular tissue in the newborns (<xref ref-type="bibr" rid="B38">Hale,
1933</xref>).</p>
<p>Between the 1950s and 1960s thalidomide was extensively used as sedative and to treat
morning nausea during pregnancy in Europe, Australia, Canada, Japan and Brazil.
Thalidomide use during pregnancy caused limb reduction defects in thousands of newborns,
leading to its ban in most countries since 1961 (<xref ref-type="bibr" rid="B46">Kim and
Scialli, 2011</xref>). The thalidomide tragedy caused an increasing interest about
drug exposure during pregnancy and the mechanism of action of teratogenic agents on
embryo-fetal abnormality development.</p>
<p>Humans are exposed to millions of potential deleterious substances and hazardous
conditions daily. However, only a small part of these substances have been tested in
animals and even fewer were confirmed as a teratogenic for humans, as teratogenicity
studies cannot be conducted in humans due to ethical reasons (<xref ref-type="bibr" rid="B45">Kalter, 2003</xref>).</p>
</sec>
<sec>
<title>Principles of Teratology</title>
<p>Teratology studies establish relationships between environmental agents and anatomical
and physiological changes in the fetus (<xref ref-type="bibr" rid="B30">Finnell,
1999</xref>; <xref ref-type="bibr" rid="B45">Kalter, 2003</xref>). We present below
the six basic principles that determine teratogenic effects (<xref ref-type="bibr" rid="B79">Wilson, 1977</xref>; <xref ref-type="bibr" rid="B30">Finnell,
1999</xref>).</p>
<sec>
<title>Maternal-fetal genotype</title>
<p>A teratogenic effect depends on maternal-fetal genotype and on how embryos interact
with their surroundings. Due to these conditions, newborns exposed to a specific dose
of the same teratogenic can show different phenotypes. Teratogens are capable of
interacting with some genes, modifying morpho-functional patterns and resulting in
either a major susceptibility or resistance to harmful substances. Some biochemical
pathways can also respond in distinct ways to different agents, affecting even more
malformation patterns (<xref ref-type="bibr" rid="B13">Cassina <italic>et
al.</italic>, 2012</xref>).</p>
</sec>
<sec>
<title>Mechanisms of action</title>
<p>The most common mechanisms of action of teratogens are hyperacetylation, cholesterol
imbalance, alteration of folate metabolism and folate antagonism, retinoic acid
imbalance, endocrine disruption, vascular disruption and oxidative stress (<xref ref-type="bibr" rid="B35">Giavini and Menegola, 2012</xref>).</p>
<sec>
<title>Hyperacetylation</title>
<p>Hyperacetylation may occur due to the inhibition of histone deacetylase enzyme
(HDAC), and the acetylation status of the histone affects the modulation of
chromatin structure and gene expression, interfering with the embryonic
development. HDAC inhibitors have been used as anticonvulsant drugs (valproic
acid) and for cancer treatment, once they prevent tumorigenesis. Among
anticancerdrugs are trichostatin A (TSA), apicidin and sodium butyrate. These
drugs are able to induce hyperacetylation in animal embryos, leading to congenital
malformations, such as neural tube and axial skeletal defects (<xref ref-type="bibr" rid="B48">Menegola <italic>et al.</italic>, 2005</xref>).</p>
</sec>
<sec>
<title>Cholesterol imbalance</title>
<p>A high amount of cholesterol is required for fetal development. This biomolecule
is supplied by the mother during early pregnancy and transported to the fetus
across the placenta, while during late pregnancy, cholesterol biosynthesis will
depend on the fetus’ own production (<xref ref-type="bibr" rid="B77">Waterham,
2006</xref>). Drugs used for the treatment of hypercholesterolemia, such as
statins, act by blocking HMG-CoA reductase, the enzyme involved with cholesterol
biosynthesis. HMG-CoA reductase is converted to mevalonate (<xref ref-type="bibr" rid="B16">Charlton-Menys and Durrington, 2008</xref>), interrupting the
synthesis of cholesterol, and thus can cause adverse effects on the developing
fetus (<xref ref-type="bibr" rid="B28">Edison and Muenke 2004</xref>).</p>
</sec>
<sec>
<title>Alteration in folate metabolism and folate antagonism</title>
<p>Folate or water-soluble vitamin B acts as a co-enzyme in biochemical reactions, as
a receiver or donor of one-carbon units, and it is involved in purine and
pyrimidine synthesis and in DNA methylation. Increased cell growth and tissue
proliferation during embryogenesis demands an increase in DNA synthesis, for which
the presence of folate is essential. Some drugs can compete with dihydrofolate
reductase and block the conversion of folate to tetrahydrofolate. Among these
drugs are methotrexate, sulfasalazine, triamterene and trimethoprim. Other drugs,
such as anti-epileptic drugs, can interfere in folate absorption or influence
folate degradation (including valproic acid and carbamazepine phenytoin). The most
common birth defects involving these drugs are neural tube defects, orofacial
clefts and limb defects (<xref ref-type="bibr" rid="B71">van Gelder <italic>et
al.</italic>, 2010</xref>).</p>
</sec>
<sec>
<title>Retinoic acid imbalance</title>
<p>An imbalance between synthesis and degradation of retinoic acid can lead to an
excess or deficiency of this acid, resulting in deleterious effects on cells and
embryos, once this Vitamin A precursor is closely related to vertebrate
morphogenesis. However, retinoic acid is also a signaling molecule in neural crest
cells, which will originate various cell types and structures, such as
intramembranous bone, cartilage, peripheral nerves and Schwann cells, and muscles,
amongst others. Drugs such as isotretinoin can contribute to retinoic acid
imbalance and lead to craniofacial and axial skeleton malformations (<xref ref-type="bibr" rid="B35">Giavini and Menegola, 2012</xref>).</p>
</sec>
<sec>
<title>Endocrine disruptors</title>
<p>Endocrine disruptors may interfere with the release of hormones and in reactions
mediated by hormone receptors (<xref ref-type="bibr" rid="B71">van Gelder
<italic>et al.</italic>, 2010</xref>). Diethylstilbestrol, oral
contraceptives, fertility treatment drugs and other endocrine disruptive
chemicals, which can include bisphenol A and phthalates, act as endocrine
disruptors (<xref ref-type="bibr" rid="B71">van Gelder <italic>et al.</italic>,
2010</xref>). These teratogenic substances can cross the placenta and lead to
fetal genital malformations (<xref ref-type="bibr" rid="B59">Raman-Wilms
<italic>et al.</italic>, 1995</xref>)</p>
</sec>
<sec>
<title>Vascular disruption</title>
<p>Changes in the development of veins, arteries and capillaries will disturb blood
perfusion in fetal tissues. These maternal-fetal blood disturbances can include
hyperperfusion, hypoperfusion, hypoxia and obstruction, and are caused by
anatomical problems, maternal chronic diseases or exposure to teratogenic agents
during pregnancy, such as misoprostol, phenytoin, cocaine, ergotamine, and some
vasodilator and vasoconstrictor drugs. Structural birth defects are the most
commonly reported, particularly limb defects (<xref ref-type="bibr" rid="B41">Holmes, 2002</xref>).</p>
</sec>
<sec>
<title>Oxidative stress</title>
<p>Oxidative damage to cellular macromolecules such as lipids, proteins, DNA and RNA
is caused by reactive oxygen species (ROS), which provide oxidation-reduction
reactions (<xref ref-type="bibr" rid="B78">Wells <italic>et al.</italic>,
1997</xref>). Exogenous ROS sources include ultraviolet light (UV), UVA and UVB
radiation, ionizing radiation, and chemical agents, while endogenous sources are
related to cellular metabolism or oxidase enzymes (<xref ref-type="bibr" rid="B39">Hansen, 2006</xref>; <xref ref-type="bibr" rid="B71">van Gelder <italic>et
al.</italic>, 2010</xref>; <xref ref-type="bibr" rid="B35">Giavini and
Menegola 2012</xref>). Some of these agents (also called proteratogens) can be
bioactivated by embryonic cytochrome P450 enzymes. Their teratogenic effect will
depend on the intracellular balance between proteratogen bioactivation, molecular
target damage, maternal proteratogen elimination, and repair of damaged cells
(<xref ref-type="bibr" rid="B80">Winn and Wells, 1995</xref>; <xref ref-type="bibr" rid="B78">Wells <italic>et al.</italic>, 1997</xref>), as
illustrated in <xref ref-type="fig" rid="f1">Figure 1</xref>. Among drugs that
induce oxidative stress are thalidomide, valproic acid, phenytoin, alcohol, (<xref ref-type="bibr" rid="B71">van Gelder <italic>et al.</italic>, 2010</xref>), and
anticancer drugs (<xref ref-type="bibr" rid="B19">Conklin 2004</xref>).</p>
<fig id="f1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>Teratogenesis pathways due to oxidative stress.</title>
</caption>
<graphic xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-gf01"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Conceptus development stage</title>
<p>Organisms present distinct sensitivity to external agents according to their
gestational age. A conceptus is a fertilized egg cell until the 3<sup>rd</sup> week
of gestation. The period from the 3<sup>rd</sup> to the 8<sup>th</sup> week it is
called embryonic phase, and from the 9<sup>th</sup> week onward the fetal phase
(<xref ref-type="bibr" rid="B52">Niakan <italic>et al.</italic>, 2012</xref>). The
critical phases of gestation are represented in <xref ref-type="fig" rid="f2">Figure
2</xref>.</p>
<fig id="f2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<title>Critical stages of human embryological development.</title>
</caption>
<graphic xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-gf02"></graphic>
</fig>
<p>The two initial weeks after fertilization, in which the zygote is undergoing mitotic
cell division is called the ‘all-or-nothing’ phase; in case a contact with a
teratogenic agent occurs, it can result either in spontaneous abortion or in a normal
embryo-fetal development. If teratogenic exposure occurs between the 3<sup>rd</sup>
and 8<sup>th</sup> week of gestation, a period in which most of the morphological
structures develop, it can lead to considerable phenotypical changes in the embryo,
such as alterations in the central nervous system, limbs and face. From the
9<sup>th</sup> week of gestation some organs are still developing, like external
genitalia and brain, and exposure to teratogens can culminate in functional
abnormalities. However most morphological characteristics are preserved from this
phase onward (<xref ref-type="bibr" rid="B67">Shepard, 1979</xref>; <xref ref-type="bibr" rid="B52">Niakan <italic>et al.</italic>, 2012</xref>).</p>
</sec>
<sec>
<title>Nature of the agent</title>
<p>Teratogenic agents can affect the embryo in different ways, according to the
teratogen's nature. Physical teratogenic agents, such as ionizing radiation, affect
the embryo directly. Drugs and other chemical substances on the other hand are
previously metabolized by the mother's organism before reaching the fetus. This
metabolism can either activate or inactivate relevant metabolites, resulting in
different teratogenic susceptibilities (<xref ref-type="bibr" rid="B30">Finnell,
1999</xref>; <xref ref-type="bibr" rid="B36">Gilbert-Barness, 2010</xref>; <xref ref-type="bibr" rid="B52">Niakan <italic>et al.</italic>, 2012</xref>).</p>
</sec>
<sec>
<title>Dose-response relationship</title>
<p>Considering basic principles of dose-response, prolonged teratogen exposure leads to
worsened embryo-fetal sequelae. Dose is also a major factor, with evidence of short
exposures to high teratogen doses leading to more deleterious effects (<xref ref-type="bibr" rid="B18">Cohlan, 1963</xref>; <xref ref-type="bibr" rid="B71">van
Gelder <italic>et al.</italic>, 2010</xref>).</p>
</sec>
<sec>
<title>Final manifestation</title>
<p>The resulting teratogenic effects are spontaneous abortion, fetal loss, embryo-fetal
morphological abnormalities, intrauterine growth restriction, and functional
disabilities, such as intellectual disability (<xref ref-type="bibr" rid="B30">Finnell, 1999</xref>; <xref ref-type="bibr" rid="B36">Gilbert-Barness,
2010</xref>).</p>
<p>Teratologists use Shepard's seven criteria to establish human teratogenicity (<xref ref-type="bibr" rid="B68">Shepard, 1994</xref>): 1) proven exposure to the agent
during the critical stages of prenatal development; 2) consistent findings on two or
more high-quality epidemiological studies (control of confounding factors, sufficient
number of cases, exclusion of positive and negative bias, prospective studies, if
possible); 3) careful delineation of clinical cases; 4) rare environmental exposure
that is associated with the rare defect (three or more cases, at least); 5)
teratogenicity in experimental animals; 6) the association should make biological
sense; and 7) experimental proof that the agent acts in an unaltered state. Criteria
1-4 are considered essential. criteria 5, 6, and 7 are helpful but not essential.</p>
</sec>
</sec>
<sec>
<title>Teratogen categories</title>
<p>Teratogenic agents can be categorized into: I) drugs and substances, II) physical
agents, III) environmental agents, IV) maternal infections, and V) maternal conditions
(<xref ref-type="bibr" rid="B36">Gilbert-Barness, 2010</xref>).
<inline-supplementary-material content-type="local-data" id="d35e616" mime-subtype="pdf" mimetype="application" xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl01.pdf">Table
S1</inline-supplementary-material> (supplementary material) presents 44 teratogenic
agents and their characteristics, as well as their respective birth defects.</p>
</sec>
<sec>
<title>Teratogenic risks</title>
<p>Due to concerns about teratogenic risks regarding medicinal drugs, the Food and Drug
Administration (FDA) created a risk classification for these substances during an
international symposium of the Teratology Society in 1992 (<xref ref-type="bibr" rid="B4">Alván <italic>et al.</italic>, 1995</xref>). Substances are classified
following a progressive risk order (A, B, C, D and X) (<xref ref-type="bibr" rid="B31">Food and Drug Administration, 2014a</xref>; <xref ref-type="bibr" rid="B4">Alván
<italic>et al.</italic>, 1995</xref>): A) controlled studies did not show risk to
the fetus; B) absence of risk to humans or results from tests on animals did not show
fetal risk; C) risks cannot be rejected; controlled studies in humans are scarce or
inexistent; although animals studies had positive results, there is no human data
available; there may be adverse effects on the fetus (drug benefits must justify fetal
risk; D) studies have shown risk to the fetus (substance prescription depends on the
mother's need, to preserve the mother's life); X) contraindicated in pregnancy; risk to
the fetus is greater than the benefit of the drug.</p>
<p>However, as this classification allowed for misinterpretation and errors in prescribing
decisions, the FDA removed pregnancy letter categories (A, B, C, D, and X), and
published a new final rule, the “Pregnancy and Lactation Labeling Rule” (PLLR), for
classification based on a narrative structure rather than a category system, which
provides a clearer description of potential risks of drug exposure during pregnancy.
From June 30, 2015, these labeling changes came into effect, to which prescription of
drugs and biological products have to comply. This final rule requires the use of the
following subsections: I) <underline>Pregnancy</underline> - information about use of
the drug in pregnant women, which includes the dosing and potential risks to the
developing fetus; information about registries of pregnant women affected by a drug or
biological product, and a recommendation of inclusion in the drug label of the existence
of any pregnancy registries; II) <underline>Lactation</underline> - information about
using the drug while breastfeeding, which includes the amount of drug in breast milk and
possible effects on the breastfed child; III) <underline>Reproductive Potential of
Females and Males</underline> - information about the need for pregnancy testing,
contraception recommendations, and infertility related to the drug (<xref ref-type="bibr" rid="B84">Food and Drug Administration, 2014b</xref>).</p>
</sec>
<sec>
<title>Why are teratogens a public health problem?</title>
<p>Preexisting public health problems, such as alcohol and drug consumption, malnutrition
of pregnant woman (<xref ref-type="bibr" rid="B63">Scholl and Johnson, 2000</xref>),
precarious health conditions, lack of infrastructure and information (<xref ref-type="bibr" rid="B47">McMichael <italic>et al.</italic>, 2005</xref>) contribute
to the contact of pregnant women with teratogenic agents and may interact as risk
factors for fetal outcome. Other factors, such as illiteracy, familiar issues and low
income aggravate the situation (<xref ref-type="bibr" rid="B53">Nutbeam, 2006</xref>),
impacting infant mortality and costs on specialized medical treatment, and aggravating
other public health issues.</p>
</sec>
<sec>
<title>Survey of birth defects cases in Brazil</title>
<p>The survey data are from the online platform of the Brazilian Ministry of Health (MoH)
based on records of the Unified Health System (SUS). DATASUS (<ext-link ext-link-type="uri" xlink:href="http://www.datasus.gov.br/DATASUS/index.php?area=02">http://www2.datasus.gov.br/DATASUS/index.php?area = 02</ext-link>) is a computerized
system that provides a database with information about birth statistics (mortality and
live births), epidemiology and morbidity, health indicators, and demographic and
socioeconomic information.</p>
<p>The SINASC (Information System of Live Births) and SIM (Mortality Information System)
databases, which have information about the number of cases of children born with birth
defects (<xref ref-type="fig" rid="f3">Figure 3A</xref>) and the number of fetal deaths
(<xref ref-type="fig" rid="f3">Figure 3B</xref>) from 2008 to 2013, registered
121,233 infants with congenital anomalies, an annual average of 20,205 cases (<xref ref-type="fig" rid="f3">Figure 3A</xref>). If we consider that the Brazilian annual
birth rate average of this period is about 2,900,000 (SINASC), there is a 0.7%
prevalence of births with anomalies. Although this may seem a small number, it is worth
noting that the ~20,000 infants born with anomalies every year directly impact the
public health system. However, studies have shown that there is a clear underreporting,
as the rate for birth defects in humans is around 3% (<xref ref-type="bibr" rid="B55">Parker <italic>et al.</italic>, 2010</xref>; <xref ref-type="bibr" rid="B81">Xu
<italic>et al.</italic>, 2016</xref>). Depending on the disability, these children
will require specific treatments, ranging from educational specialists, to physical
therapy, or surgical interventions. Moreover, in addition to these birth defects there
were 9,178 fetal deaths due to congenital anomalies reported during the same period,
corresponding to an annual average of 1,530 (<xref ref-type="fig" rid="f3">Figure
3B</xref>).</p>
<fig id="f3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<title>Comprehensive survey of birth defects in Brazil from 2008 to 2013. A) Number
of children born with birth defects. B) Number of fetal deaths. C) Number of
hospitalizations involving birth defects per year. D) Number of deaths of
hospitalized patients due to birth defects. E) Costs associated with treatment and
on hospitalization's admissions.</title>
</caption>
<graphic xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-gf03"></graphic>
</fig>
<p>Another survey was performed in the SIH/SUS (Hospital Information System/ Unified Health
System) databases, using as a parameter the hospital morbidity lists by ICD-10
(International Classification of Diseases) from 2008 to 2013. The following variables
were searched: infant hospitalizations involving birth defects per year (<xref ref-type="fig" rid="f3">Figure 3C</xref>), deaths of hospitalized patients due to
birth defects (<xref ref-type="fig" rid="f3">Figure 3D</xref>), and average cost of
hospitalizations due to birth defects (<xref ref-type="fig" rid="f3">Figure 3E</xref>).
<xref ref-type="fig" rid="f3">Figure 3C</xref> shows that during this period there
were a total of 494,714 infant hospitalizations due to birth defects, which represents
an annual average of 82,452.</p>
<p>There were 13,050 reported deaths (<xref ref-type="fig" rid="f3">Figure 3D</xref>), with
an average of 2,175 per year. Thus, the number of children dying after hospitalization
is higher than the number of fetal deaths due to congenital anomalies. About 3% of
children who were hospitalized with birth defects died, which, added to the 1,530 fetal
deaths, totals 3,705 annual deaths. The total cost associated with infant
hospitalization involving congenital anomalies was 46,550 USD during these six years
(<xref ref-type="fig" rid="f3">Figure 3E</xref>), corresponding to an annual average
of 7,758 USD.</p>
<p>Furthermore, in addition to hospital costs, patients with chronic conditions will need
continuous treatment, increasing even more the associated costs. These costs can include
drugs, physiotherapy, speech therapy, occupational therapy and special education, and in
many instances the mother quits her job to care for the child (<xref ref-type="bibr" rid="B42">Horovitz <italic>et al.</italic>, 2005</xref>).</p>
<p>
<inline-supplementary-material content-type="local-data" id="d35e744" mime-subtype="pdf" mimetype="application" xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl02.pdf">Tables
S2</inline-supplementary-material>-<inline-supplementary-material content-type="local-data" id="d35e747" mime-subtype="pdf" mimetype="application" xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl06.pdf">S6</inline-supplementary-material> are attached as supplementary material and
contain the raw data (2008 to 2013) from the Brazilian Ministry of Health website. As
can be seen, there is a lack of specification in the records jeopardizing the
identification of the etiology of the possible teratogens. Better epidemiological
information would be very important for the detection of new teratogens, as well as for
their proper control. The microcephaly epidemics, as we will show below, is an example
of how the lack of proper registries in many countries made it difficult to identify the
real impact of the Zika virus infection in pregnancy and the extent of the resulting
birth defects.</p>
</sec>
<sec>
<title>Brazilian cases of teratogenesis</title>
<sec>
<title>Microcephaly outbreak in Brazil and Zika prenatal virus infection</title>
<p>In 2015 there was a sudden appearance of Zika virus (ZIKV) infections in Brazil,
especially in the Northeast region (<xref ref-type="bibr" rid="B12">Campos <italic>et
al.</italic>, 2015</xref>). Climatic factors, lack of infrastructure, and the
population's negligence offered favorable conditions for the proliferation of
<italic>Aedes sp.</italic> mosquitoes, the Zika virus vector (<xref ref-type="bibr" rid="B20">Costa <italic>et al.</italic>, 2008</xref>).
Furthermore, recent studies suggest a potential sexual transmission of Zika virus
(<xref ref-type="bibr" rid="B51">Musso <italic>et al.</italic>, 2015</xref>; <xref ref-type="bibr" rid="B6">Atkinson <italic>et al.</italic>, 2016</xref>; <xref ref-type="bibr" rid="B24">D’Ortenzio <italic>et al.</italic>, 2016</xref>),
increasing the concern received from public authorities. The principal reason for
alarm is the increased risk of the unborn babies to develop neurological and brain
abnormalities, characterized by microcephaly, when infected by Zika virus during
pregnancy (<xref ref-type="bibr" rid="B49">Mlakar <italic>et al.</italic>,
2016</xref>; <xref ref-type="bibr" rid="B60">Rasmussen <italic>et al.</italic>,
2016</xref>).</p>
<p>From 2010 to 2014 there was an average of 160 cases of microcephaly per year in
Brazil (<xref ref-type="bibr" rid="B82">Brazil Ministry of Health, 2015</xref>). A
drastic increase was reported from October 22, 2015 to June 18, 2016, with 8,039
suspected and 1,616 confirmed cases of microcephaly (<xref ref-type="bibr" rid="B83">Brazil Ministry of Health, 2016</xref>). The cases occurred in 576
municipalities, throughout all 26 Brazilian States and the Federal District. In a
study analyzing the first 1,501 cases of microcephaly reported to the Brazilian MoH,
602 were included as possibly related to ZIKV prenatal infection (depending on the
level of laboratorial, radiological or clinical evidence) (<xref ref-type="bibr" rid="B32">França <italic>et al.</italic>, 2016</xref>).</p>
<p>Microcephaly can be caused by genetic, environmental or multifactorial causes (<xref ref-type="bibr" rid="B2">Alcantara and O’Driscoll, 2014</xref>). The astonishing
increase in the reported number of cases of microcephaly in 2015 led the Brazilian
MoH to declare state of emergency in the country (<xref ref-type="bibr" rid="B82">Brazil MoH, 2015</xref>), and on February, 2016, the World Health Organization
(WHO), in turn, declared the large number of cases of microcephaly and neurological
disorders and their possible relationship with ZIKV a Public Health Emergency of
International Concern (PHEIC) (<xref ref-type="bibr" rid="B87">World Health
Organization, 2016</xref>).</p>
<p>Soon after, the ZIKV genome was detected in the amniotic fluid of pregnant women
whose fetuses presented microcephaly (<xref ref-type="bibr" rid="B11">Calvet
<italic>et al.</italic>, 2016</xref>), as well as in the brain of aborted
fetuses, in urine, and in cerebrospinal fluid (<xref ref-type="bibr" rid="B8">Brasil
<italic>et al.</italic>, 2016</xref>; <xref ref-type="bibr" rid="B49">Mlakar
<italic>et al.</italic>, 2016</xref>).</p>
<p>
<xref ref-type="bibr" rid="B60">Rasmussen <italic>et al.</italic> (2016)</xref>,
using Shepard's criteria for defining a human teratogen, concluded that there was
enough evidence to establish the causal relationship between ZIKV infection during
pregnancy and microcephaly, in addition to other brain anomalies. Studies in mice
revealed that the Brazilian Zika virus (ZIKVBR) is capable of infecting the fetus,
leading to intrauterine growth restriction, including microcephaly (<xref ref-type="bibr" rid="B23">Cugola <italic>et al.</italic>, 2016</xref>). Other
studies showed that ZIKV targets human brain cells (<xref ref-type="bibr" rid="B33">Garcez <italic>et al.</italic>, 2016</xref>), clearly revealing the association
between ZIKV infection during the first trimester of pregnancy and microcephaly risk
(<xref ref-type="bibr" rid="B44">Johansson <italic>et al.</italic>,
2016</xref>).</p>
<p>Microcephaly can lead to several complications, such as intellectual disability,
growth retardation, strabism, epilepsy, metabolic disorders, and cerebral palsy
(<xref ref-type="bibr" rid="B76">Watemberg <italic>et al.</italic>, 2002</xref>;
<xref ref-type="bibr" rid="B5">Ashwal <italic>et al.</italic>, 2009</xref>), with
an enormous economic and social impact for the country in future years. Therefore,
effective actions should be implemented immediately to contain the ZIKV spread. Those
actions should include better access to public sanitation and health policies,
control of the <italic>Aedes</italic> vector, which also transmits other tropical
diseases such as dengue and yellow fever, along with the search for effective
vaccination and pharmacological treatment.</p>
</sec>
<sec>
<title>Misoprostol</title>
<p>In developing countries there is an early sexual initiation and lack of family
planning. Women tend to be aware of pregnancy weeks or even months later (<xref ref-type="bibr" rid="B26">De Moura and Gomes, 2014</xref>), and there is a high
rate of undesired pregnancies.</p>
<p>In countries were abortion is illegal, as in Brazil, intentionally induced
clandestine abortions contributes to high numbers of maternal mortality. Around 5% of
Brazilian women end up opting for the illegal use of misoprostol to terminate
unwanted pregnancies (<xref ref-type="bibr" rid="B72">Vargas <italic>et al.</italic>,
2000</xref>). This medical drug is a synthetic prostaglandin E1 analog, originally
prescribed to treat gastric ulcers, which stimulate uterine contractions, leading to
miscarriage. In Brazil, it has been banned from the market because of its use as an
illegal abortion method (<xref ref-type="bibr" rid="B22">Costa, 1998</xref>; <xref ref-type="bibr" rid="B64">Schuler <italic>et al.</italic>, 1999</xref>; <xref ref-type="bibr" rid="B25">da Silva Dal Pizzol <italic>et al.</italic>,
2006</xref>; <xref ref-type="bibr" rid="B3">Allen and O’Brien, 2009</xref>).
Misoprostol alone does not present great efficiency in inducing abortions, and can
induce fetal abnormalities, especially if used in the first trimester of pregnancy
(<xref ref-type="bibr" rid="B37">Gonzalez <italic>et al.</italic>, 1998</xref>;
<xref ref-type="bibr" rid="B22">Costa, 1998</xref>; <xref ref-type="bibr" rid="B25">da Silva Dal Pizzol <italic>et al.</italic>, 2006</xref>; <xref ref-type="bibr" rid="B3">Allen and O’Brien, 2009</xref>). Furthermore, the
increased use of drugs or herbs with perceived abortive actions by the population
highlights the lack of control in selling and using prescription medications.</p>
<p>A cohort study of pregnant women treated in prenatal services in six Brazilian
capitals revealed that 707 women used products to induce menstruation, which includes
herbal teas (34.4%), sex hormones (28.3%), and misoprostol (17%) (<xref ref-type="bibr" rid="B58">Pizzol <italic>et al.</italic>, 2008</xref>). The
congenital anomaly risk was 2.74 times greater for fetuses exposed to misoprostol
when compared to unexposed fetuses. Misoprostol is associated mainly to congenital
paralysis of the 6<sup>th</sup> and 7<sup>th</sup> cranial nerves and to limb
reduction defects due to fetal vascular disruption (<xref ref-type="bibr" rid="B37">Gonzalez <italic>et al.</italic>, 1998</xref>; <xref ref-type="bibr" rid="B72">Vargas <italic>et al.</italic>, 2000</xref>).</p>
</sec>
<sec>
<title>Thalidomide</title>
<p>Even after the immense international repercussion of the teratogenic potential
effects of thalidomide, many cases of newborn malformation involving this medicine
were registered in Brazil in different years. Thalidomide is a drug indicated for the
treatment of erythema nodosum leprosum (ENL), and more recently, to a number of
different medical conditions, due to its immunomodulatory properties (<xref ref-type="bibr" rid="B73">Vianna <italic>et al.</italic>, 2011</xref>, <xref ref-type="bibr" rid="B74">2015</xref>; <xref ref-type="bibr" rid="B46">Kim and
Scialli, 2011</xref>;). The Latin-American Collaborative Study of Congenital
Malformations (ECLAMC) reported 34 thalidomide embryopathy cases in South America
from the 1960s to 1990s, of which 33 where in Brazil. Most of these cases involved
mothers treated for leprosy, whose babies presented birth defects, such as
phocomelia, hypoplastic glenoid, absence of thumbs, absence or hypoplasia of radius,
a third arm bone, and polydactyly (<xref ref-type="bibr" rid="B14">Castilla
<italic>et al.</italic>, 1996</xref>).</p>
<p>Three cases were reported from 2005 to 2010. From those, four involved mothers that
underwent treatment for ENL and were unaware of pregnancy, while the third case
involved self-medication of a pregnant woman who took thalidomide prescribed for her
mother, who was being treated for multiple myeloma (<xref ref-type="bibr" rid="B65">Schuler-Faccini <italic>et al.</italic>, 2007</xref>). The majority of cases
involves lack of medical information, which is related to public health.</p>
<p>Despite safety concerns, the Brazilian population has a high consumption of
thalidomide. The state of São Paulo leads the thalidomide drug distribution rates
(5,889,210 thalidomide tablets), followed by Minas Gerais and Rio de Janeiro, from
2005 to 2010. In this period, there were 2,802 reported cases of limb reduction
defects, with 192 cases compatible with a thalidomide embryopathy phenotype (TEP)
(<xref ref-type="bibr" rid="B74">Vianna <italic>et al.</italic>, 2015</xref>).
This demonstrates the seriousness of this public health issue.</p>
</sec>
<sec>
<title>Alcohol</title>
<p>In 2012, alcohol was responsible for almost 3.3 million of deaths, corresponding to
5.9% of the total number of deaths worldwide. Excessive alcohol consumption prevails
among adults aged 20-39 years, although alcohol use by young people starts at early
ages – even from 12.5 years old (<xref ref-type="bibr" rid="B75">Vieira <italic>et
al.</italic>, 2007</xref>; <xref ref-type="bibr" rid="B86">World Health
Organization, 2015b</xref>). Alcohol abuse during pregnancy can lead to Neonatal
Abstinence Syndrome in babies. Alcohol is the teratogenic agent responsible for the
Fetal Alcohol Syndrome (FAS), as well as Fetal Alcohol Spectrum Disorders (FASD),
being a major non-genetic cause of intellectual disability and behavioral problems
(<xref ref-type="bibr" rid="B1">Abel and Sokol, 1987</xref>; <xref ref-type="bibr" rid="B50">Momino <italic>et al.</italic>, 2012</xref>; <xref ref-type="bibr" rid="B15">Chapman and Wu, 2013</xref>; <xref ref-type="bibr" rid="B54">O’Leary
<italic>et al.</italic>, 2013</xref>).</p>
<p>In 2015 a study was carried out in a Brazilian orphanage in Recife to investigate the
frequency of FASD. Children were evaluated by a multidisciplinary team, and the
following results were obtained: 50% of the childrens mothers were reported as known
alcohol abusers. Of these children, 18% presented general developmental delay, 3% had
intellectual disabilities, 27% had cognitive impairment, 14% had attention
deficit/hyperactivity, and 3% presented autism. A total of 17% presented FASD, three
children presented FAS, six presented partial FAS, and seven presented neurological
disorder related to alcohol. About 16% of these children presented ocular changes,
such as low vision, strabism and morphological changes of optic nerves, which shows
the devastating effects of drug abuse during pregnancy. (<xref ref-type="bibr" rid="B69">Strömland <italic>et al.</italic>, 2014</xref>)</p>
</sec>
<sec>
<title>Illicit drugs</title>
<p>Illicit drug consumption during pregnancy is another public health problem involving
a potential embryo-fetal effect. The effects of these substances include low birth
weight, intrauterine growth restriction and placental abruption, as well as premature
birth or spontaneous abortion (<xref ref-type="bibr" rid="B40">Holbrook and Rayburn,
2014</xref>). Cocaine and its derivatives, such as crack and heroin, may have
harmful effects on pregnancy (<xref ref-type="bibr" rid="B17">Cherukuri <italic>et
al.</italic>, 1988</xref>; <xref ref-type="bibr" rid="B62">Rizk <italic>et
al.</italic>, 1996</xref>; <xref ref-type="bibr" rid="B21">Costa <italic>et
al.</italic>, 2012</xref>). The extent of the problem can be estimated by the
increase in the demand of medical care and costs with hospitalization and specialized
treatment for drug-addicted pregnant women, as well as the increase in the number of
premature births. Another issue is the increased rate of sexually transmitted
diseases or other maternal infections related to illicit drug and alcohol use (<xref ref-type="bibr" rid="B70">Tüzün <italic>et al.</italic>, 1999</xref>; <xref ref-type="bibr" rid="B43">Hwang <italic>et al.</italic>, 2000</xref>), which can
also be teratogenic, like syphilis.</p>
</sec>
</sec>
<sec>
<title>Concluding remarks</title>
<p>This review presented fundamental aspects of teratogenic agents, bringing an overview
about the number of cases of congenital anomalies, and their contribution to an increase
in mortality rates, hospitalizations and treatments expenses for the Brazilian Unified
Health System. We also present cases of congenital malformations involving teratogens,
as well as the definitive classification of Zika virus infection as a teratogen and now
a real public health problem.</p>
<p>Congenital anomalies caused by teratogenic agents are essentially avoidable, with a
great impact on public health, on the economic and on social aspects. Public policies to
prevent, care for, and treat these disabilities are extremely important to manage this
public health issue. To address these problems, a collaborative agreement among the
United Nations (UN), the WHO, the United Nations Children's Fund (UNICEF) and government
leaders in 2010 planned a series of low-cost and high-impact interventions to improve
neonatal and infant health quality (<xref ref-type="bibr" rid="B85">World Health
Organization, 2015a</xref>). The lack of public health structure in developing
countries, however, still causes problems, reducing the viability of the proposal.
Congenital abnormalities and neglected diseases are somewhat comparable, as both
problems do not receive the necessary attention and prevail in developing regions. In
Brazil, income transfers helped millions of people out of extreme poverty, but are still
far from solving public health problems in the country. An intervention is needed,
especially in the peripheral regions, with the application of preventive policies (<xref ref-type="bibr" rid="B27">Di Renzo <italic>et al.</italic>, 2015</xref>). These
policies may differ according to the countries’ characteristics, but they should by all
means emphasize health education of professionals, and the public, investment in primary
reproductive healthcare, pregnancy planning, basic sanitation, and reliable registries
with epidemiological data on congenital anomalies.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank the funding agencies FAPESP (Grant Nr. 2011/13997-8),
CNPq (Grants Nr. 311323/2011-1, Nr. 131306/2013-8 and 205453/2014-7) and CAPES for
scholarships and financial support.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1">
<p>
<italic>Associate Editor: Carlos F.M. Menck</italic>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>1987</year>
<article-title>Incidence of fetal alcohol sydrome and economic impact of fas-related
anamalies</article-title>
<source/>Drug Alcohol Depend
          <volume>19</volume>
<fpage>51</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">3545731</pub-id>
</element-citation>
</ref>
<ref id="B2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcantara</surname>
<given-names>D</given-names>
</name>
<name>
<surname>O’Driscoll</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Congenital microcephaly</article-title>
<source/>Am J Med Genet Part C Semin Med Genet
          <volume>166</volume>
<fpage>124</fpage>
<lpage>139</lpage>
</element-citation>
</ref>
<ref id="B3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>BM</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Uses of misoprostol in obstetrics and gynecology</article-title>
<source/>Rev Obstet Gynecol
          <volume>2</volume>
<fpage>159</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="pmid">19826573</pub-id>
</element-citation>
</ref>
<ref id="B4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alván</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Danielsson</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Kihlström</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lundborg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Prame</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ridley</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sannerstedt</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>1995</year>
<article-title>Classification of drugs for teratogenic risk</article-title>
<source/>Eur J Clin Pharmacol
          <volume>48</volume>
<fpage>177</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="pmid">7589037</pub-id>
</element-citation>
</ref>
<ref id="B5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashwal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Michelson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Plawner</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Practice parameter: Evaluation of the child with microcephaly (an
evidence-based review): Report of the Quality Standards Subcommittee of the
American Academy of Neurology and the Practice Committee of the Child Neurology
Society</article-title>
<source/>Neurology
          <volume>73</volume>
<fpage>887</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="pmid">19752457</pub-id>
</element-citation>
</ref>
<ref id="B6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atkinson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hearn</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Afrough</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lumley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Aarons</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Hewson</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Detection of Zika Virus in semen</article-title>
<source/>Emerg Infect Dis
          <volume>22</volume>
<fpage>160</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">26691533</pub-id>
</element-citation>
</ref>
<ref id="B7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrow</surname>
<given-names>MV</given-names>
</name>
</person-group>
<year>1971</year>
<article-title>A brief history of teratology to the early 20th
century</article-title>
<source/>Teratology
          <volume>4</volume>
<fpage>119</fpage>
<lpage>129</lpage>
</element-citation>
</ref>
<ref id="B8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brasil</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>JP</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Raja Gabaglia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Damasceno</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wakimoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ribeiro Nogueira</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Carvalho de Sequeira</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Machado Siqueira</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abreu de Carvalho</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Cotrim da Cunha</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<year>2016</year>
<article-title>Zika virus infection in pregnant women in Rio de Janeiro - Preliminary
report</article-title>
<source/>N Engl J Med
          <volume>375</volume>
<fpage>2321</fpage>
<lpage>2334</lpage>
<pub-id pub-id-type="pmid">26943629</pub-id>
</element-citation>
</ref>
<ref id="B9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brent</surname>
<given-names>RL</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>The cause and prevention of human birth defects: What have we learned
in the past 50 years?</article-title>
<source/>Congenit Anom (Kyoto)
          <volume>41</volume>
<fpage>3</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="B10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bronberg</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schuler-Faccini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ramallo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Alfaro</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dipierri</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Spatial and temporal analysis of infant mortality from congenital
malformations in Brazil (1996-2010)</article-title>
<source/>J Community Genet
          <volume>5</volume>
<fpage>269</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="pmid">24081606</pub-id>
</element-citation>
</ref>
<ref id="B11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Aguiarv</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Sampaio</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>de Filippis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Fabri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Araujo</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>de Sequeira</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>de Mendonça</surname>
<given-names>MCL</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<year>2016</year>
<article-title>Detection and sequencing of Zika virus from amniotic fluid of fetuses
with microcephaly in Brazil: A case study</article-title>
<source/>Lancet Infect Dis
          <volume>16</volume>
<fpage>653</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="pmid">26897108</pub-id>
</element-citation>
</ref>
<ref id="B12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campos</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Bandeira</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Sardi</surname>
<given-names>SI</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Zika virus outbreak, Bahia, Brazil</article-title>
<source/>Emerg Infect Dis
          <volume>21</volume>
<fpage>1885</fpage>
<lpage>1886</lpage>
<pub-id pub-id-type="pmid">26401719</pub-id>
</element-citation>
</ref>
<ref id="B13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salviati</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Di Gianantonio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Clementi</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Genetic susceptibility to teratogens: State of the art</article-title>
<source/>Reprod Toxicol
          <volume>34</volume>
<fpage>186</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">22659091</pub-id>
</element-citation>
</ref>
<ref id="B14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castilla</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ashton-Prolla</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barreda-Mejia</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brunoni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cavalcanti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Correa-Neto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delgadillo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dutra</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Felix</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Giraldo</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<year>1996</year>
<article-title>Thalidomide, a current teratogen in South America</article-title>
<source/>Teratology
          <volume>54</volume>
<fpage>273</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="pmid">9098920</pub-id>
</element-citation>
</ref>
<ref id="B15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>SLC</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Li-Tzy</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Substance abuse among individuals with intellectual
disabilities</article-title>
<source/>Res Dev Disabil
          <volume>33</volume>
<fpage>1147</fpage>
<lpage>1156</lpage>
</element-citation>
</ref>
<ref id="B16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charlton-Menys</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Durrington</surname>
<given-names>PN</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Human cholesterol metabolism and therapeutic molecules</article-title>
<source/>Exp Physiol
          <volume>93</volume>
<fpage>27</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">18165431</pub-id>
</element-citation>
</ref>
<ref id="B17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherukuri</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Minkoff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Parekh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Glass</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>1988</year>
<article-title>A cohort study of alkaloidal cocaine (“ crack”) in
prenancy</article-title>
<source/>Obstet Gynecol
          <volume>72</volume>
<fpage>147</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="pmid">3393357</pub-id>
</element-citation>
</ref>
<ref id="B18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohlan</surname>
<given-names>SQ</given-names>
</name>
</person-group>
<year>1963</year>
<article-title>Teratogenic agents and congenital malformations</article-title>
<source/>J Pediatr
          <volume>63</volume>
<fpage>650</fpage>
<lpage>659</lpage>
<pub-id pub-id-type="pmid">14074423</pub-id>
</element-citation>
</ref>
<ref id="B19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conklin</surname>
<given-names>KA</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Chemotherapy-associated oxidative stress: Impact on chemotherapeutic
effectiveness</article-title>
<source/>Integr Cancer Ther
          <volume>3</volume>
<fpage>294</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">15523100</pub-id>
</element-citation>
</ref>
<ref id="B20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>JJ da</given-names>
</name>
<name>
<surname>da Souza</surname>
<given-names>CM de</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Dinâmica populacional de <italic>Aedes aegypti</italic> (L) em área
urbana de alta incidência de dengue</article-title>
<source/>Rev Soc Bras Med Trop
          <volume>41</volume>
<fpage>309</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="pmid">18719816</pub-id>
</element-citation>
</ref>
<ref id="B21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Soibelman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zanchet</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>PDM</given-names>
</name>
<name>
<surname>Alberto</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Salgado</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Pregnant crack addicts in a psychiatric unit</article-title>
<source/>J Bras Psiquiatr
          <volume>61</volume>
<fpage>8</fpage>
<lpage>12</lpage>
</element-citation>
</ref>
<ref id="B22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>SH</given-names>
</name>
</person-group>
<year>1998</year>
<article-title>Commercial availability of misoprostol and induced abortion in
Brazil</article-title>
<source/>Int J Gynaecol Obstet
          <volume>63</volume>
<issue>Suppl 1</issue>
<fpage>S131</fpage>
<lpage>S139</lpage>
<pub-id pub-id-type="pmid">10075223</pub-id>
</element-citation>
</ref>
<ref id="B23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cugola</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Freitas</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>JLM</given-names>
</name>
<name>
<surname>Guimarães</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Benazzato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pignatari</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<year>2016</year>
<article-title>The Brazilian Zika virus strain causes birth defects in experimental
models</article-title>
<source/>Nature
          <volume>534</volume>
<fpage>267</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="pmid">27279226</pub-id>
</element-citation>
</ref>
<ref id="B24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Ortenzio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Matheron</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lamballerie</surname>
<given-names>X de</given-names>
</name>
<name>
<surname>Hubert</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Piorkowski</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Maquart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Descamps</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Damond</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yazdanpanah</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Leparc-Goffart</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Evidence of sexual transmission of Zika virus</article-title>
<source/>N Engl J Med
          <volume>374</volume>
<fpage>2195</fpage>
<lpage>2198</lpage>
<pub-id pub-id-type="pmid">27074370</pub-id>
</element-citation>
</ref>
<ref id="B25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva Dal Pizzol</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Knop</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Mengue</surname>
<given-names>SS</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Prenatal exposure to misoprostol and congenital anomalies: Systematic
review and meta-analysis</article-title>
<source/>Reprod Toxicol
          <volume>22</volume>
<fpage>666</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">16750609</pub-id>
</element-citation>
</ref>
<ref id="B26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Moura</surname>
<given-names>LNB</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>KRO</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Planejamento familiar: Uso dos serviços de saúde por jovens com
experiência de gravidez</article-title>
<source/>Cienc Saude Colet
          <volume>19</volume>
<fpage>853</fpage>
<lpage>863</lpage>
</element-citation>
</ref>
<ref id="B27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Renzo</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Conry</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>J</given-names>
</name>
<name>
<surname>DeFrancesco</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>DeNicola</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>McCue</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Richmond</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<year>2015</year>
<article-title>International Federation of Gynecology and Obstetrics opinion on
reproductive health impacts of exposure to toxic environmental
chemicals</article-title>
<source/>Int J Gynecol Obstet
          <volume>131</volume>
<fpage>219</fpage>
<lpage>225</lpage>
</element-citation>
</ref>
<ref id="B28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edison</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Muenke</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Central nervous system and limb anomalies in case reports of
first-trimester statin exposure</article-title>
<source/>N Engl J Med
          <volume>350</volume>
<fpage>1579</fpage>
<lpage>1582</lpage>
<pub-id pub-id-type="pmid">15071140</pub-id>
</element-citation>
</ref>
<ref id="B29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egbe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Uppu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stroustrup</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Congenital malformations in the newborn population: A population study
and analysis of the effect of sex and prematurity</article-title>
<source/>Pediatr Neonatol
          <volume>56</volume>
<fpage>25</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">25267275</pub-id>
</element-citation>
</ref>
<ref id="B30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finnell</surname>
<given-names>RH</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>Teratology: General considerations and principles</article-title>
<source/>J Allergy Clin Immunol
          <volume>103</volume>
<fpage>337</fpage>
<lpage>342</lpage>
</element-citation>
</ref>
<ref id="B31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Food and Drug Administration</collab>
</person-group>
<year>2014a</year>
<article-title>Content and format of labeling for human prescription drug and
biological products requirements for pregnancy and lactation
labeling</article-title>
<source/>Dep Health Hum Serv Food Federal Regist
          <volume>79</volume>
<fpage>1</fpage>
<lpage>144</lpage>
</element-citation>
</ref>
<ref id="B32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>França</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Schuler-Faccini</surname>
<given-names>Faccini</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Henriques</surname>
<given-names>CMP</given-names>
</name>
<name>
<surname>Carmo</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Pedi</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Serruya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Silveira</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
</person-group>
<year>2016</year>
<article-title>Congenital Zika virus syndrome in Brazil: A case series of the first
1501 livebirths with complete investigation</article-title>
<source/>Lancet
          <volume>388</volume>
<fpage>891</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="pmid">27372398</pub-id>
</element-citation>
</ref>
<ref id="B33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcez</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Loiola</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>RM da</given-names>
</name>
<name>
<surname>Higa</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Trindade</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Delvecchio</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nascimento</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Brindeiro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tanuri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rehen</surname>
<given-names>SK</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Zika virus impairs growth in human neurospheres and brain
organoids</article-title>
<source/>Science
          <volume>352</volume>
<fpage>816</fpage>
<lpage>818</lpage>
<pub-id pub-id-type="pmid">27064148</pub-id>
</element-citation>
</ref>
<ref id="B34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcias</surname>
<given-names>GDL</given-names>
</name>
<name>
<surname>Schüler-Faccini</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>The beliefs of mothers in southern Brazil regarding risk-factors
associated with congenital abnormalities</article-title>
<source/>Genet Mol Biol
          <volume>27</volume>
<fpage>147</fpage>
<lpage>153</lpage>
</element-citation>
</ref>
<ref id="B35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giavini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Menegola</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Biomarkers of teratogenesis: Suggestions from animal
studies</article-title>
<source/>Reprod Toxicol
          <volume>34</volume>
<fpage>180</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">22610102</pub-id>
</element-citation>
</ref>
<ref id="B36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert-Barness</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Teratogenic causes of malformations</article-title>
<source/>Ann Clin Lab Sci
          <volume>40</volume>
<fpage>99</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="pmid">20421621</pub-id>
</element-citation>
</ref>
<ref id="B37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Marques-Dias</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Sugayama</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Da Paz</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Huson</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>LB</given-names>
</name>
</person-group>
<year>1998</year>
<article-title>Congenital abnormalities in Brazilian children associated with
misoprostol misuse in first trimester of pregnancy</article-title>
<source/>Lancet
          <volume>351</volume>
<fpage>1624</fpage>
<lpage>1627</lpage>
<pub-id pub-id-type="pmid">9620717</pub-id>
</element-citation>
</ref>
<ref id="B38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hale</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>1933</year>
<article-title>Pigs born without eye balls</article-title>
<source/>J Hered
          <volume>24</volume>
<fpage>105</fpage>
<lpage>110</lpage>
</element-citation>
</ref>
<ref id="B39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>JM</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Oxidative stress as a mechanism of teratogenesis</article-title>
<source/>Birth Defects Res C Embryo Today
          <volume>78</volume>
<fpage>293</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="pmid">17315243</pub-id>
</element-citation>
</ref>
<ref id="B40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holbrook</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Rayburn</surname>
<given-names>WF</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Teratogenic risks from exposure to illicit drugs</article-title>
<source/>Obstet Gynecol Clin North Am
          <volume>41</volume>
<fpage>229</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="pmid">24845487</pub-id>
</element-citation>
</ref>
<ref id="B41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>LB</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Teratogen-induced limb defects</article-title>
<source/>Am J Med Genet
          <volume>112</volume>
<fpage>297</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="pmid">12357474</pub-id>
</element-citation>
</ref>
<ref id="B42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horovitz</surname>
<given-names>DDG</given-names>
</name>
<name>
<surname>Llerena</surname>
<given-names>JC</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Mattos</surname>
<given-names>RA</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Atenção aos defeitos congênitos no Brasil: Panorama
atual</article-title>
<source/>Cad Saúde Pública
          <volume>21</volume>
<fpage>1055</fpage>
<lpage>1064</lpage>
<pub-id pub-id-type="pmid">16021243</pub-id>
</element-citation>
</ref>
<ref id="B43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Zack</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bull</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rickman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Holleman</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Prevalence of sexually transmitted infections and associated risk
factors among populations of drug abusers</article-title>
<source/>Clin Infect Dis
          <volume>31</volume>
<fpage>920</fpage>
<lpage>926</lpage>
<pub-id pub-id-type="pmid">11049771</pub-id>
</element-citation>
</ref>
<ref id="B44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mier-y-Teran-Romero</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Reefhuis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gilboa</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Hills</surname>
<given-names>SL</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Zika and the risk of microcephaly</article-title>
<source/>N Engl J Med
          <volume>375</volume>
<fpage>1</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">27222919</pub-id>
</element-citation>
</ref>
<ref id="B45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalter</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Teratology in the 20th century: Environmental causes of congenital
malformations in humans and how they were established</article-title>
<source/>Neurotoxicol Teratol
          <volume>25</volume>
<fpage>131</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="pmid">12748001</pub-id>
</element-citation>
</ref>
<ref id="B46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Scialli</surname>
<given-names>AR</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Thalidomide: The tragedy of birth defects and the effective treatment
of disease</article-title>
<source/>Toxicol Sci
          <volume>122</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">21507989</pub-id>
</element-citation>
</ref>
<ref id="B47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMichael</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Volmink</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Evidence-based public health: What does it offer developing
countries?</article-title>
<source/>J Public Health (Oxf)
          <volume>27</volume>
<fpage>215</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">15820994</pub-id>
</element-citation>
</ref>
<ref id="B48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menegola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Di Renzo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Broccia</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Prudenziati</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Minucci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Massa</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Giavini</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Inhibition of histone deacetylase activity on specific embryonic
tissues as a new mechanism for teratogenicity</article-title>
<source/>Birth Defects Res Part B - Dev Reprod Toxicol
          <volume>74</volume>
<fpage>392</fpage>
<lpage>398</lpage>
</element-citation>
</ref>
<ref id="B49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mlakar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Korva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tul</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Popovic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Poljak-Prijatelj</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mraz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kolenc</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Resman</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Vesnaver</surname>
<given-names>VT</given-names>
</name>
<name>
<surname>Voduek</surname>
<given-names>VF</given-names>
</name>
<etal></etal>
</person-group>
<year>2016</year>
<article-title>Zika virus associated with microcephaly</article-title>
<source/>N Engl J Med
          <volume>374</volume>
<fpage>951</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="pmid">26862926</pub-id>
</element-citation>
</ref>
<ref id="B50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Momino</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Félix</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Abeche</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Zandoná</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Scheibler</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>RZ</given-names>
</name>
<name>
<surname>Schüler-Faccini</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Maternal drinking behavior and Fetal Alcohol Spectrum disorders in
adolescents with criminal behavior in southern Brazil</article-title>
<source/>Genet Mol Biol
          <volume>35</volume>
<fpage>960</fpage>
<lpage>965</lpage>
<pub-id pub-id-type="pmid">23412828</pub-id>
</element-citation>
</ref>
<ref id="B51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Musso</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nhan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Teissier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cao-Lormeau</surname>
<given-names>VM</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Potential sexual transmission of zika virus</article-title>
<source/>Emerg Infect Dis
          <volume>21</volume>
<fpage>359</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="pmid">25625872</pub-id>
</element-citation>
</ref>
<ref id="B52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niakan</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pera</surname>
<given-names>RAR</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Human pre-implantation embryo development</article-title>
<source/>Development
          <volume>139</volume>
<fpage>829</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="pmid">22318624</pub-id>
</element-citation>
</ref>
<ref id="B53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nutbeam</surname>
<given-names>DON</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Health literacy as a public health goal: A challenge for contemporary
health education and communication strategies into the 21st
century</article-title>
<source/>Health Promot Int
          <volume>15</volume>
<fpage>259</fpage>
<lpage>268</lpage>
</element-citation>
</ref>
<ref id="B54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Leary</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bourke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>D’Antoine</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bartu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bower</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Intellectual disability: Population-based estimates of the proportion
attributable to maternal alcohol use disorder during pregnancy</article-title>
<source/>Dev Med Child Neurol
          <volume>55</volume>
<fpage>271</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="pmid">23241019</pub-id>
</element-citation>
</ref>
<ref id="B55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Canfield</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Rickard</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>RS</given-names>
</name>
<etal></etal>
</person-group>
<year>2010</year>
<article-title>Updated national birth prevalence estimates for selected birth defects
in the United States, 2004 – 2006</article-title>
<source/>Birth Defects Res (Part A)
          <volume>88</volume>
<fpage>1008</fpage>
<lpage>1016</lpage>
</element-citation>
</ref>
<ref id="B56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Passos-Bueno</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Bertola</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Horovitz</surname>
<given-names>DDG</given-names>
</name>
<name>
<surname>de Faria Ferraz</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Brito</surname>
<given-names>LA</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Genetics and genomics in Brazil: A promising future</article-title>
<source/>Mol Genet Genomic Med
          <volume>2</volume>
<fpage>280</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="pmid">25077170</pub-id>
</element-citation>
</ref>
<ref id="B57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrini</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Damus</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Poschman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Davidoff</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Mattison</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Contribution of birth defects to infant mortality in the United
States</article-title>
<source/>Teratology
          <volume>66</volume>
<issue>Suppl 1</issue>
<fpage>S3</fpage>
<lpage>S6</lpage>
<pub-id pub-id-type="pmid">12239736</pub-id>
</element-citation>
</ref>
<ref id="B58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzol T da</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Sanseverino</surname>
<given-names>MTV</given-names>
</name>
<name>
<surname>Mengue</surname>
<given-names>SS</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Exposure to misoprostol and hormones during pregnancy and risk of
congenital anomalies</article-title>
<source/>Cad Saude Publica
          <volume>24</volume>
<fpage>1447</fpage>
<lpage>1453</lpage>
<pub-id pub-id-type="pmid">18545770</pub-id>
</element-citation>
</ref>
<ref id="B59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raman-Wilms</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wighardt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Einarson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Koren</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>1995</year>
<article-title>Fetal genital effects of first-trimester sex hormone exposure: A
meta-analysis</article-title>
<source/>Obstet Gynecol
          <volume>85</volume>
<fpage>141</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">7800312</pub-id>
</element-citation>
</ref>
<ref id="B60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Jamieson</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Honein</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>LR</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Zika virus and birth defects - Reviewing the evidence for
causality</article-title>
<source/>N Engl J Med
          <volume>374</volume>
<fpage>1981</fpage>
<lpage>1987</lpage>
<pub-id pub-id-type="pmid">27074377</pub-id>
</element-citation>
</ref>
<ref id="B61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reidpath</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Allotey</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Infant mortality rate as an indicator of population
health</article-title>
<source/>J Epidemiol Community Health
          <volume>57</volume>
<fpage>344</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="pmid">12700217</pub-id>
</element-citation>
</ref>
<ref id="B62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizk</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Atterbury</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Groome</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<year>1996</year>
<article-title>Reproductive risks of cocaine</article-title>
<source/>Hum Reprod Update
          <volume>2</volume>
<fpage>43</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">9079402</pub-id>
</element-citation>
</ref>
<ref id="B63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scholl</surname>
<given-names>TO</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>WG</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Folic acid: Influence on the outcome of pregnancy</article-title>
<source/>Am J Clin Nutr
          <volume>71</volume>
<fpage>1295S</fpage>
<lpage>1303S</lpage>
<pub-id pub-id-type="pmid">10799405</pub-id>
</element-citation>
</ref>
<ref id="B64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schüler</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pastuszak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sanseverino</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Orioli</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Brunoni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ashton-Prolla</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Silva da Costa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giugliani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Couto</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Brandao</surname>
<given-names>SB</given-names>
</name>
<etal></etal>
</person-group>
<year>1999</year>
<article-title>Pregnancy outcome after exposure to misoprostol in Brazil: A
prospective, controlled study</article-title>
<source/>Reprod Toxicol
          <volume>13</volume>
<fpage>147</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="pmid">10213522</pub-id>
</element-citation>
</ref>
<ref id="B65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuler-Faccini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>RCF</given-names>
</name>
<name>
<surname>de Sousa</surname>
<given-names>ACM</given-names>
</name>
<name>
<surname>Maximino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Luna</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>IVD</given-names>
</name>
<name>
<surname>Waldman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Castilla</surname>
<given-names>EE</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>New cases of thalidomide embryopathy in Brazil</article-title>
<source/>Birth Defects Res A Clin Mol Teratol
          <volume>79</volume>
<fpage>671</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="pmid">17676592</pub-id>
</element-citation>
</ref>
<ref id="B66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shepard</surname>
<given-names>TH</given-names>
</name>
</person-group>
<year>1982</year>
<article-title>Detection of human teratogenic agents</article-title>
<source/>J Pediatr
          <volume>101</volume>
<fpage>810</fpage>
<lpage>815</lpage>
<pub-id pub-id-type="pmid">7131168</pub-id>
</element-citation>
</ref>
<ref id="B67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shepard</surname>
<given-names>TH</given-names>
</name>
</person-group>
<year>1979</year>
<article-title>Teratogenicity of therapeutic agents</article-title>
<source/>Curr Probl Pediatr
          <volume>10</volume>
<fpage>1</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="B68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shepard</surname>
<given-names>TH</given-names>
</name>
</person-group>
<year>1994</year>
<article-title>“Proof” of human teratogenicity</article-title>
<source/>Teratology
          <volume>50</volume>
<fpage>97</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">7801306</pub-id>
</element-citation>
</ref>
<ref id="B69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strömland</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>LO</given-names>
</name>
<name>
<surname>Mirzaei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fontes de Oliveira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Marcelino Bandim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Parente Ivo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Fetal alcohol spectrum disorders among children in a Brazilian
orphanage</article-title>
<source/>Birth Defects Res A Clin Mol Teratol
          <volume>103</volume>
<fpage>178</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">25371388</pub-id>
</element-citation>
</ref>
<ref id="B70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tüzün</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tüzün</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>Alcohol intake and sexually transmitted diseases</article-title>
<source/>Clin Dermatol
          <volume>17</volume>
<fpage>469</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="pmid">10497734</pub-id>
</element-citation>
</ref>
<ref id="B71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Gelder</surname>
<given-names>MMHJ</given-names>
</name>
<name>
<surname>van Rooij</surname>
<given-names>IALM</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Zielhuis</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>de Jong-van den Berg</surname>
<given-names>LTW</given-names>
</name>
<name>
<surname>Roeleveld</surname>
<given-names>N</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Teratogenic mechanisms of medical drugs</article-title>
<source/>Hum Reprod Update
          <volume>16</volume>
<fpage>378</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="pmid">20061329</pub-id>
</element-citation>
</ref>
<ref id="B72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vargas</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Schuler-Faccini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brunoni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>VF</given-names>
</name>
<name>
<surname>Sugayama</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Albano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Llerena</surname>
<given-names>JC</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Almeida</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<year>2000</year>
<article-title>Prenatal exposure to misoprostol and vascular disruption defects: A
case-control study</article-title>
<source/>Am J Med Genet
          <volume>95</volume>
<fpage>302</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="pmid">11186881</pub-id>
</element-citation>
</ref>
<ref id="B73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vianna</surname>
<given-names>FSL</given-names>
</name>
<name>
<surname>Lopez-Camelo</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>JCL</given-names>
</name>
<name>
<surname>Sanseverino</surname>
<given-names>MTV</given-names>
</name>
<name>
<surname>Dutra</surname>
<given-names>MDG</given-names>
</name>
<name>
<surname>Castilla</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Schüler-Faccini</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Epidemiological surveillance of birth defects compatible with
thalidomide embryopathy in Brazil</article-title>
<source/>PLoS One
          <volume>6</volume>
<elocation-id>e21735</elocation-id>
<pub-id pub-id-type="pmid">21754997</pub-id>
</element-citation>
</ref>
<ref id="B74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vianna</surname>
<given-names>FSL</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>MZ</given-names>
</name>
<name>
<surname>Sanseverino</surname>
<given-names>MTV</given-names>
</name>
<name>
<surname>Morelo</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Rabello D de</surname>
<given-names>L</given-names>
<suffix>Neto</suffix>
</name>
<name>
<surname>Lopez-Camelo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Camey</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Schuler-Faccini</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Pharmacoepidemiology and thalidomide embryopathy surveillance in
Brazil</article-title>
<source/>Reprod Toxicol
          <volume>53</volume>
<fpage>63</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">25828060</pub-id>
</element-citation>
</ref>
<ref id="B75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vieira</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Laranjeira</surname>
<given-names>RR</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Alcohol and adolescents: Study to implement municipal
policies</article-title>
<source/>Rev Saude Publica
          <volume>41</volume>
<fpage>1</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="B76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watemberg</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Silver</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lerman-Sagie</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Significance of microcephaly among children with developmental
disabilities</article-title>
<source/>J Child Neurol
          <volume>17</volume>
<fpage>117</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">11952071</pub-id>
</element-citation>
</ref>
<ref id="B77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waterham</surname>
<given-names>HR</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Defects of cholesterol biosynthesis</article-title>
<source/>FEBS Lett
          <volume>580</volume>
<fpage>5442</fpage>
<lpage>5449</lpage>
<pub-id pub-id-type="pmid">16876788</pub-id>
</element-citation>
</ref>
<ref id="B78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wells</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Laposa</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Nicol</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Parman</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Winn</surname>
<given-names>LM</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Oxidative damage in chemical teratogenesis</article-title>
<source/>Mutat Res
          <volume>396</volume>
<fpage>65</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="pmid">9434860</pub-id>
</element-citation>
</ref>
<ref id="B79">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>JG</given-names>
</name>
</person-group>
<year>1977</year>
<chapter-title>Current status of teratology: General principles and
mechanisms derived from animal studies</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Wilson</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>FC</given-names>
</name>
</person-group>
<source/>Handbook of Teratology
          <publisher-name>Plenum Press</publisher-name>
<publisher-loc>New York</publisher-loc>
<size units="pages">488 pp</size>
</element-citation>
</ref>
<ref id="B80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winn</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>1995</year>
<article-title>Free radical-mediated mechanisms of anti-convulsant
teratogenicity</article-title>
<source/>Eur J Neurol
          <volume>2</volume>
<fpage>5</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">24283575</pub-id>
</element-citation>
</ref>
<ref id="B81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kochanek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bastian</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Deaths: Final data for 2013. National vital statistics
reports</article-title>
<source/>Natl Cent Heal Stat
          <volume>64</volume>
<fpage>1</fpage>
<lpage>117</lpage>
</element-citation>
</ref>
</ref-list>
<ref-list>
<title>Internet resources</title>
<ref id="B82">
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Brazil Ministry of Health</collab>
</person-group>
<year>2015</year>
<source/>Microcephaly- epidemiological bulletin
          <comment>
<ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/images/pdf/2015/novembro/30/Microcefalia-2-boletim.pdf">http://portalsaude.saude.gov.br/images/pdf/2015/novembro/30/Microcefalia-2-boletim.pdf</ext-link>
</comment>
<date-in-citation content-type="access-date">accessed June 22,
2016</date-in-citation>
</element-citation>
</ref>
<ref id="B83">
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Brazil Ministry of Health</collab>
</person-group>
<year>2016</year>
<source/>Microcephaly- epidemiological bulletin
          <comment>
<ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/index.php/cidadao/principal/agencia-saude/24202-ministerio-da-saude-confirma-1-616-casos-de-microcefalia-em-todo-o-pais">http://portalsaude.saude.gov.br/index.php/cidadao/principal/agencia-saude/24202-ministerio-da-saude-confirma-1-616-casos-de-microcefalia-em-todo-o-pais</ext-link>
</comment>
<date-in-citation content-type="access-date">accessed June 22,
2016</date-in-citation>
</element-citation>
</ref>
<ref id="B84">
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Food and Drug Administration</collab>
</person-group>
<year>2014b</year>
<source/>Code of Federal Regulations Title 21
          <comment>(21CFR201.57). Avalilable: <ext-link ext-link-type="uri" xlink:href="http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/">http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr =
201.57</ext-link></comment>
<date-in-citation content-type="access-date">accessed June 2, 2014</date-in-citation>
</element-citation>
</ref>
<ref id="B85">
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<year>2015a</year>
<article-title>Congenital anomalies</article-title>
<source/>Fact sheet No370
          <comment>
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs370/en/">http://www.who.int/mediacentre/factsheets/fs370/en/</ext-link>
</comment>
<date-in-citation content-type="access-date">accessed November 23,
2015</date-in-citation>
</element-citation>
</ref>
<ref id="B86">
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<year>2015b</year>
<article-title>Alcohol</article-title>
<source/>Fact sheet N°349
          <comment>
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs349/en/">http://www.who.int/mediacentre/factsheets/fs349/en/</ext-link>
</comment>
<date-in-citation content-type="access-date">accessed November 23,
2015</date-in-citation>
</element-citation>
</ref>
<ref id="B87">
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<year>2016</year>
<source/>WHO statement on the first meeting of the International Health Regulations
(2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in
neurological disorders and neonatal malformations
          <comment>
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/">http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/</ext-link>
</comment>
<date-in-citation content-type="access-date">accessed February 25,
2016</date-in-citation>
</element-citation>
</ref>
</ref-list>
<app-group>
<app id="app1">
<title>Supplementary material</title>
<p>The following online material is available for this article:</p>
<p>
<supplementary-material content-type="local-data" id="suppl1"><label>Table S1</label><caption><title>- Main teratogen categories and respective embryo-fetal effects during
pregnancy.</title></caption><media xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl01.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="suppl2"><label>Table S2</label><caption><title>- Cases involving congenital anomalies from 2008 to 2013.</title></caption><media xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl02.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="suppl3"><label>Table S3</label><caption><title>- Fetal deaths involving congenital anomalies from 2008 to 2013.</title></caption><media xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl03.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="suppl4"><label>Table S4</label><caption><title>- Infant hospitalizations involving congenital anomalies from 2008 to
2013.</title></caption><media xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl04.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="suppl5"><label>Table S5</label><caption><title>- Number of deaths of infant hospitalized involving congenital anomalies
from 2008 to 2013.</title></caption><media xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl05.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="suppl6"><label>Table S6</label><caption><title>- Average cost in US dollars of hospitalizations involving congenital
anomalies from 2008 to 2013</title></caption><media xlink:href="1415-4757-gmb-1678-4685-GMB-2016-0179-Suppl06.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p>
</app>
</app-group>
</back>
</article>
</pmc-articleset>